{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:19:34Z","timestamp":1784204374528,"version":"3.55.0"},"reference-count":51,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RMHP"],"DOI":"10.2147\/rmhp.s442692","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T04:25:05Z","timestamp":1700627105000},"page":"2531-2541","source":"Crossref","is-referenced-by-count":11,"title":["The Rate of Infusion Represents an Important Aspect of Administering Anticancer Agents"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Mei-Juan","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di-Fei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3314-0451","authenticated-orcid":true,"given":"Quan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11]]},"reference":[{"key":"ref1","unstructured":"Joint Commission International, Joint Commission on Accreditation of Healthcare Organizations. Joint Commission International Accreditation Standards for Hospitals. 7th ed. Oak Brook, IL: Joint Commission Resources; 2020."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2146\/sp150001","volume":"72","author":"Goldspiel","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1097\/MPH.0000000000000044","volume":"36","author":"Dhamija","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/TCRM.S59199","volume":"10","author":"Zhu","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2147\/RMHP.S374563","volume":"15","author":"Park","year":"2022","journal-title":"Risk Manag Healthc Policy"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/RMHP.S16059","volume":"4","author":"Garcia-Alonso","year":"2011","journal-title":"Risk Manag Healthc Policy"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3171\/jns.1999.91.2.0221","volume":"91","author":"Hiraga","year":"1999","journal-title":"J Neurosurg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1200\/JCO.1998.16.1.301","volume":"16","author":"Piedbois","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s00280-004-0985-9","volume":"56","author":"Hoshino","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref10","first-page":"111","volume":"21","author":"Zhou","year":"2006","journal-title":"Chin Med Sci J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/phar.1769","volume":"36","author":"Pasternak","year":"2016","journal-title":"Pharmacotherapy"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ygyno.2009.10.070","volume":"116","author":"O\u2019Cearbhaill","year":"2010","journal-title":"Gynecol Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1097\/IGC.0000000000001280","volume":"28","author":"LaVigne","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00280-007-0454-3","volume":"61","author":"Petrioli","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"10781552231192007","DOI":"10.1177\/10781552231192007","volume":"1","author":"Huynh","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/s0090-8258(89)80033-2","volume":"32","author":"Thigpen","year":"1989","journal-title":"Gynecol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/jcpt.12781","volume":"44","author":"Mense","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/1097-0142(19900215)65:4<870::AID-CNCR2820650407>3.0.CO;2-D","volume":"65","author":"Shapira","year":"1990","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e1681","DOI":"10.1002\/cnr2.1681","volume":"6","author":"Cranmer","year":"2023","journal-title":"Cancer Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1158\/1078-0432.CCR-22-1564","volume":"29","author":"Cranmer","year":"2023","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00520-016-3399-4","volume":"25","author":"Perreault","year":"2017","journal-title":"Support Care Cancer"},{"key":"ref22","unstructured":"RxList [homepage on the Internet]. BICNU; 2021. Available from: https:\/\/www.rxlist.com\/bicnu-drug.htm#indications. Accessed September 24, 2023."},{"key":"ref23","unstructured":"RxList [homepage on the Internet]. Gemzar; 2018. Available from: https:\/\/www.rxlist.com\/gemzar-drug.htm#dosage. Accessed September 23, 2023."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/bjc.2013.738","volume":"110","author":"Khatri","year":"2014","journal-title":"Br J Cancer"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.lungcan.2006.03.004","volume":"52","author":"Cappuzzo","year":"2006","journal-title":"Lung Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00432-007-0250-9","volume":"134","author":"Kosmas","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1200\/JCO.1998.16.11.3537","volume":"16","author":"L\u00e9vy","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00001813-200006000-00003","volume":"11","author":"van Zuylen","year":"2000","journal-title":"Anticancer Drugs"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/s0090-8258(03)00459-1","volume":"91","author":"Jennens","year":"2003","journal-title":"Gynecol Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1200\/JCO.2002.20.2.574","volume":"20","author":"Gelderblom","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/mco.2022.2572","volume":"17","author":"Taira","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12032-014-0276-1","volume":"31","author":"Yanmaz","year":"2014","journal-title":"Med Oncol"},{"key":"ref33","first-page":"923","volume":"20","author":"Makris","year":"2015","journal-title":"J BUON"},{"key":"ref34","unstructured":"RxList [homepage on the Internet]. Rituxan; 2021. Available from: http:\/\/www.rxlist.com\/rituxan-drug\/indications-dosage.htm. Accessed September 23, 2023."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/phar.1420","volume":"34","author":"Swan","year":"2014","journal-title":"Pharmacotherapy"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1177\/1078155220977898","volume":"27","author":"Moore","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.clml.2023.03.006","volume":"23","author":"Stakiw","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.clml.2020.02.014","volume":"20","author":"Hamadeh","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00280-020-04223-9","volume":"87","author":"Gao","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref40","unstructured":"RxList [homepage on the Internet]. Cyramza; 2022. Available from: https:\/\/www.rxlist.com\/cyramza-drug.htm#dosage. Accessed September 24, 2023."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e11822","DOI":"10.1097\/MD.0000000000011822","volume":"97","author":"Yao","year":"2018","journal-title":"Medicine"},{"key":"ref42","unstructured":"RxList [homepage on the Internet]. Paclitaxel; 2022. Available from: https:\/\/www.rxlist.com\/paclitaxel\/generic-drug.htm. Accessed September 24, 2023."},{"key":"ref43","unstructured":"RxList [homepage on the Internet]. Rituxan; 2021. Available from: https:\/\/www.rxlist.com\/rituxan-drug.htm#dosage. Accessed September 24, 2023."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1200\/JCO.2010.32.5340","volume":"29","author":"Mikkelsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12016-021-08877-y","volume":"62","author":"Sao","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ygyno.2017.03.015","volume":"145","author":"O\u2019Malley","year":"2017","journal-title":"Gynecol Oncol"},{"key":"ref47","unstructured":"RxList [homepage on the Internet]. Abraxane; 2021. Available from: https:\/\/www.rxlist.com\/abraxane-drug.htm. Accessed September 24, 2023."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/1078155214556008","volume":"22","author":"Dranitsaris","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"ref49","unstructured":"RxList [homepage on the Internet]. DOXIL; 2022. Available from: https:\/\/www.rxlist.com\/doxil-drug.htm. Accessed September 23, 2023."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1743-7563.2010.01354.x","volume":"7","author":"Metharom","year":"2011","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1182\/blood-2012-08-452839","volume":"121","author":"Ramsey","year":"2013","journal-title":"Blood"}],"container-title":["Risk Management and Healthcare Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94577","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94577","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T04:25:11Z","timestamp":1700627111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/the-rate-of-infusion-represents-an-important-aspect-of-administering-a-peer-reviewed-fulltext-article-RMHP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":51,"URL":"https:\/\/doi.org\/10.2147\/rmhp.s442692","relation":{},"ISSN":["1179-1594"],"issn-type":[{"value":"1179-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}